# Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group

> **NCT03141398** · — · WITHDRAWN · sponsor: **Hamad Medical Corporation**

## Conditions studied

- Iron Overload
- Hemoglobinopathies
- Lymphoma
- Acute Lymphoblastic Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** Continuous Glucose Monitoring (CGM)
- **DIAGNOSTIC_TEST:** Oral Glucose Tolerance Test (OGTT)
- **DIAGNOSTIC_TEST:** T2* MRI of the Pancreas

## Key facts

- **NCT ID:** NCT03141398
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to issues with study design
- **Last updated:** 2017-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03141398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03141398, "Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03141398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*